Escherichia coli Protein Expression System for Acetylcholine Binding Proteins (AChBPs).

Nicotinic acetylcholine receptors (nAChR) are ligand gated ion channels, identified as therapeutic targets for a range of human diseases. Drug design for nAChR related disorders is increasingly using structure-based approaches. Many of these structural insights for therapeutic lead development have...

Full description

Bibliographic Details
Main Authors: Nikita Abraham, Blessy Paul, Lotten Ragnarsson, Richard J Lewis
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4909209?pdf=render
id doaj-046e26398e324d0c985f0a6729ce6abe
record_format Article
spelling doaj-046e26398e324d0c985f0a6729ce6abe2020-11-25T01:48:04ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-01116e015736310.1371/journal.pone.0157363Escherichia coli Protein Expression System for Acetylcholine Binding Proteins (AChBPs).Nikita AbrahamBlessy PaulLotten RagnarssonRichard J LewisNicotinic acetylcholine receptors (nAChR) are ligand gated ion channels, identified as therapeutic targets for a range of human diseases. Drug design for nAChR related disorders is increasingly using structure-based approaches. Many of these structural insights for therapeutic lead development have been obtained from co-crystal structures of nAChR agonists and antagonists with the acetylcholine binding protein (AChBP). AChBP is a water soluble, structural and functional homolog of the extracellular, ligand-binding domain of nAChRs. Currently, AChBPs are recombinantly expressed in eukaryotic expression systems for structural and biophysical studies. Here, we report the establishment of an Escherichia coli (E. coli) expression system that significantly reduces the cost and time of production compared to the existing expression systems. E. coli can efficiently express unglycosylated AChBP for crystallography and makes the expression of isotopically labelled forms feasible for NMR. We used a pHUE vector containing an N-terminal His-tagged ubiquitin fusion protein to facilitate AChBP expression in the soluble fractions, and thus avoid the need to recover protein from inclusion bodies. The purified protein yield obtained from the E. coli expression system is comparable to that obtained from existing AChBP expression systems. E. coli expressed AChBP bound nAChR agonists and antagonists with affinities matching those previously reported. Thus, the E. coli expression system significantly simplifies the expression and purification of functional AChBP for structural and biophysical studies.http://europepmc.org/articles/PMC4909209?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Nikita Abraham
Blessy Paul
Lotten Ragnarsson
Richard J Lewis
spellingShingle Nikita Abraham
Blessy Paul
Lotten Ragnarsson
Richard J Lewis
Escherichia coli Protein Expression System for Acetylcholine Binding Proteins (AChBPs).
PLoS ONE
author_facet Nikita Abraham
Blessy Paul
Lotten Ragnarsson
Richard J Lewis
author_sort Nikita Abraham
title Escherichia coli Protein Expression System for Acetylcholine Binding Proteins (AChBPs).
title_short Escherichia coli Protein Expression System for Acetylcholine Binding Proteins (AChBPs).
title_full Escherichia coli Protein Expression System for Acetylcholine Binding Proteins (AChBPs).
title_fullStr Escherichia coli Protein Expression System for Acetylcholine Binding Proteins (AChBPs).
title_full_unstemmed Escherichia coli Protein Expression System for Acetylcholine Binding Proteins (AChBPs).
title_sort escherichia coli protein expression system for acetylcholine binding proteins (achbps).
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2016-01-01
description Nicotinic acetylcholine receptors (nAChR) are ligand gated ion channels, identified as therapeutic targets for a range of human diseases. Drug design for nAChR related disorders is increasingly using structure-based approaches. Many of these structural insights for therapeutic lead development have been obtained from co-crystal structures of nAChR agonists and antagonists with the acetylcholine binding protein (AChBP). AChBP is a water soluble, structural and functional homolog of the extracellular, ligand-binding domain of nAChRs. Currently, AChBPs are recombinantly expressed in eukaryotic expression systems for structural and biophysical studies. Here, we report the establishment of an Escherichia coli (E. coli) expression system that significantly reduces the cost and time of production compared to the existing expression systems. E. coli can efficiently express unglycosylated AChBP for crystallography and makes the expression of isotopically labelled forms feasible for NMR. We used a pHUE vector containing an N-terminal His-tagged ubiquitin fusion protein to facilitate AChBP expression in the soluble fractions, and thus avoid the need to recover protein from inclusion bodies. The purified protein yield obtained from the E. coli expression system is comparable to that obtained from existing AChBP expression systems. E. coli expressed AChBP bound nAChR agonists and antagonists with affinities matching those previously reported. Thus, the E. coli expression system significantly simplifies the expression and purification of functional AChBP for structural and biophysical studies.
url http://europepmc.org/articles/PMC4909209?pdf=render
work_keys_str_mv AT nikitaabraham escherichiacoliproteinexpressionsystemforacetylcholinebindingproteinsachbps
AT blessypaul escherichiacoliproteinexpressionsystemforacetylcholinebindingproteinsachbps
AT lottenragnarsson escherichiacoliproteinexpressionsystemforacetylcholinebindingproteinsachbps
AT richardjlewis escherichiacoliproteinexpressionsystemforacetylcholinebindingproteinsachbps
_version_ 1725013234246746112